Á lódáil...
Harms of off‐label erythropoiesis‐stimulating agents for critically ill people
BACKGROUND: Anaemia is a common problem experienced by critically‐ill people. Treatment with erythropoiesis‐stimulating agents (ESAs) has been used as a pharmacologic strategy when the blunted response of endogenous erythropoietin has been reported in critically‐ill people. The use of ESAs becomes m...
Na minha lista:
| Foilsithe in: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
John Wiley & Sons, Ltd
2017
|
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6373621/ https://ncbi.nlm.nih.gov/pubmed/28841235 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010969.pub2 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|